US FDA flags seizure risk with certain Parkinson's drugs, seeks label warnings

US FDA flags seizure risk with certain Parkinson's drugs, seeks label warnings | Reuters Skip to main content Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv Follow Amneal Pharmaceuticals Inc Follow Novartis AG Follow Show more companies March 20 (Reuters) - The U.S. Food and Drug Administration said on Friday it has notified manufacturers of certain Parkinson's disease treatments to update their prescribing information with a new warning about a potential risk ...